Profile
| Metric | Value |
|---|---|
| Full Name | Masimo Corporation |
| Ticker | NASDAQ: MASI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | masimo.com |
| Employees | 3,600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $127.40 | |
| Price, 1D Change | -2.05% | |
| Market Cap | $7B | |
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | 1.25 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +2.26% | |
| EPS | -$5.72 | |
| EPS, 1Y Change | -479.71% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.00 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.72 | |
| EPS Estimate | $5.48 | |
| EPS Est. Change | +195.82% | |
| Revenue | $2.09B | |
| Revenue Estimate | $1.52B | |
| Revenue Est. Change | -27.39% | |
| Current Price | $127.40 | |
| Price Target | - | $182.50 |
| Price Tgt. Change | - | +43.25% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.95 | $1.51 | -48.93% | |
| $4.03 | -$5.72 | -241.81% | |
| $5.48 | N/A | +195.82% | |
| $5.90 | N/A | +203.16% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.05B | $2.05B | 0.00% | |
| $2.09B | $2.09B | +0.38% | |
| $1.52B | N/A | -27.39% | |
| $1.62B | N/A | -22.42% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -24.42% | |
| Price, 3Y | -13.89% | |
| Market Cap, 1Y | -24.26% | |
| Market Cap, 3Y | -11.90% | |
| Revenue, 1Y | +2.26% | |
| Revenue, 3Y | +69.02% | |
| EPS, 1Y | -479.71% | |
| EPS, 3Y | -243.68% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $127.40 | |
| SMA 200 | $151.97 | |
| SMA 200 vs Price | +19.28% | |
| SMA 50 | $141.50 | |
| SMA 50 vs Price | +11.07% | |
| Beta | 1.25 | |
| ATR | $3.76 | |
| 14-Day RSI | 31.13 | |
| 10-Day Volatility | 22.25% | |
| 1-Year Volatility | 41.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.00 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.09B | |
| EPS | -$5.72 | |
| Gross Profit | $1.00B | |
| Gross Margin | 47.96% | |
| Operating Profit | $37.80M | |
| Operating Margin | -50.24% | |
| Net Income | -$304.90M | |
| Net Margin | -14.56% | |
| EBITDA | $140.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.80 | |
| Current Ratio | 1.98 | |
| Quick Ratio | 1.24 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 4.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 3.99 | |
| PB Ratio | 8.45 | |
| EV/EBITDA | 30.91 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.05B | |
| Cash & Equivalents | $180.30M | |
| Total Assets | $2.63B | |
| Current Assets | $1.23B | |
| Total Liabilities | $1.57B | |
| Current Liabilities | $617.70M | |
| Total Debt | $846.10M | |
| Short Term Debt | $58.70M | |
| Accounts Payable | $252.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.40B | |
| Operating Expenses | $966.60M | |
| Cost Of Goods Sold | $1.09B | |
| SG&A | $0.00 | |
| D&A | $103.00M | |
| Interest Expense | $0.00 | |
| Income Tax | -$400.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $196.40M | |
| CFI | -$51.20M | |
| CFF | -$125.60M | |
| Capex | $51.10M | |
| Free Cash Flow | $145.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| BTIG | → | |
| B of A Securities | ||
| Wells Fargo | → | |
| BTIG | → | |
| BTIG | → | |
| Piper Sandler | → | |
| Wells Fargo | → | |
| Raymond James | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with MASI
Data Sources & References
- MASI Official Website www.masimo.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/937556/000093755625000161/0000937556-25-000161-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/937556/000093755625000032/0000937556-25-000032-index.htm
- MASI Profile on Yahoo Finance finance.yahoo.com/quote/MASI
- MASI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/masi
FAQ
What is the ticker symbol for Masimo Corporation?
The ticker symbol for Masimo Corporation is NASDAQ:MASI
Does Masimo Corporation pay dividends?
No, Masimo Corporation does not pay dividends
What sector is Masimo Corporation in?
Masimo Corporation is in the Healthcare sector
What industry is Masimo Corporation in?
Masimo Corporation is in the Medical Devices industry
What country is Masimo Corporation based in?
Masimo Corporation is headquartered in United States
When did Masimo Corporation go public?
Masimo Corporation initial public offering (IPO) was on August 8, 2007
Is Masimo Corporation in the S&P 500?
No, Masimo Corporation is not included in the S&P 500 index
Is Masimo Corporation in the NASDAQ 100?
No, Masimo Corporation is not included in the NASDAQ 100 index
Is Masimo Corporation in the Dow Jones?
No, Masimo Corporation is not included in the Dow Jones index
When was Masimo Corporation last earnings report?
Masimo Corporation's most recent earnings report was on November 4, 2025
When does Masimo Corporation report earnings?
The next expected earnings date for Masimo Corporation is February 24, 2026